Abatacept
ORENCIA
Selective T Cell Costimulation Modulator
NADAC/unit
$1471.0367
No Shortage
Tier 1: 45.0%
PA Req: 206.7%
ORENCIA is a selective T cell costimulation modulator indicated for: • the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA). (1.1) • the treatment of patient....
vs. brand ORENCIA: Generic saves up to -14610% per unit
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.